Abstract: Provided are an anti-CLDN18.2 antibody or antigen-binding fragment thereof, a nucleic acid molecule encoding the same, an immunoconjugate, bispecific molecule, chimeric antigen receptor and pharmaceutical composition comprising the same. The antibody or antigen-binding fragment thereof is used for preventing and/or treating a tumor.

Abstract: Provided are an anti-CLDN18.2 antibody or antigen-binding fragment thereof, a nucleic acid molecule encoding the same, an immunoconjugate, bispecific molecule, chimeric antigen receptor and pharmaceutical composition comprising the same. The antibody or antigen-binding fragment thereof is used for preventing and/or treating a tumor.

Abstract: A method of measuring a tissue parameter such as proteoglycan content and other relevant tissue parameters, e.g. tissue pH, in a tissue or an organ of a subject includes generating first and second frequency magnetic resonance data using T1? scans at different frequencies, wherein the frequencies are symmetric. The method also includes combining the first frequency magnetic resonance data and the second frequency magnetic resonance data to remove a number of contributions from a number of relaxation mechanisms other than chemical exchange, thereby obtaining chemical exchange-specific magnetic resonance data indicative of the tissue parameter in the tissue or the organ. The chemical exchange-specific magnetic resonance data may be used to measure the proteoglycan content in the tissue or organ.

Abstract: An exemplary methodology, procedure, system, method and computer-accessible medium can be provided to determine one or more particular frequencies of cross-relaxation between at least one molecule and at least one particular compound determine a chemical exchange based on magnetic resonance data using a further frequency which is different from the one or more particular frequencies, and derive particular information about the anatomical region of interest based on the chemical exchange.

Abstract: A method of measuring a tissue parameter such as proteoglycan content and other relevant tissue parameters, e.g. tissue pH, in a tissue or an organ of a subject includes generating first and second frequency magnetic resonance data using T1? scans at different frequencies, wherein the frequencies are symmetric. The method also includes combining the first frequency magnetic resonance data and the second frequency magnetic resonance data to remove a number of contributions from a number of relaxation mechanisms other than chemical exchange, thereby obtaining chemical exchange-specific magnetic resonance data indicative of the tissue parameter in the tissue or the organ. The chemical exchange-specific magnetic resonance data may be used to measure the proteoglycan content in the tissue or organ.

Abstract: Disclosed is a method for extracting gallium from fly ash, which comprises the following steps: crushing the fly ash and removing Fe by magnetic separation; then dissolving it by using hydrochloride acid (2) to obtain hydrochloric acid leachate; adsorbing gallium in the hydrochloric acid leachate with macro-porous cationic resin, followed by eluting to obtain the eluent (5) containing gallium; adding sodium hydroxide (6) solution into the eluent containing gallium to react and obtaining sodium metaaluminate solution containing gallium (8); introducing CO2 into the sodium metaaluminate solution containing gallium (8) for carbonation, followed by separating gallium from aluminum and obtaining aluminum-gallium double salt (15) with the gallium to alumina mass ratio being more than 1:340; adding the aluminum-gallium double salt (15) into sodium hydroxide (17) to react, followed by alkalinity-adjustment concentration to obtain alkali solution containing gallium and aluminum; electrolyzing (10) the alkali solution

Abstract: An exemplary methodology, procedure, system, method and computer-accessible medium can be provided to determine one or more particular frequencies of cross-relaxation between at least one molecule and at least one particular compound, determine a chemical exchange based on magnetic resonance data using a further frequency which is different from the one or more particular frequencies, and derive particular information about the anatomical region of interest based on the chemical exchange.

Abstract: The present invention relates to a herbicidal composition, especially used as a rape field herbicide, prepared by mixing pyrimidinyl benzylamine herbicide (Pyribambenz-propyl or Pyribambenz-isopropyl) with at least one rape field herbicide selected from a group consisting of: acetyl-CoA carboxylase (ACCase) inhibitors including quizalofop-ethyl, fluazifop-p-butyl, haloxyfop, fenoxaprop, and sethoxydim; chloro-amido herbicides including acetochlor, alachlor, napropamide, ehaprochlor, and metolachlor; ethametsulfuron; and benazolin. The composition of the present invention is of synergistic effect, reduced dosage, broadened spectrum of weed control, delayed resistance and increased safety toward rape.

Abstract: This invention relates to new 2-pyrimidinyloxy-N-aryl-benzylamine derivatives, their preparation processes and uses as chemical herbicides in agriculture. The compound has the following structure: wherein, D or E is hydrogen, halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl or C1-C4 haloalkoxy; R1 is hydrogen, halogen, C1-C4 alkyl, C1-C4 alkoxy; R2 is hydrogen, halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 carbamyl, C1-C4 alkoxycarbonyl, C1-C4 haloalkyl, cyano, nitro, carboxy or its alkali metal, alkali earth metal and organoammonium salts, C1-C4 alkylamido, C1-C4 haloalkylamido, heterocyclic amido, benzamido or substituted benzamido, benzo or substituted benzo compounds; R3 is hydrogen, C1-C4 alkanoyl, C1-C4 haloalkanoyl, benzoyl or C1-C4 alkoxyacetyl; X is CH or N; n=1-3.

Abstract: This invention relates to new 2-pyrimidinyloxy-N-aryl-benzylamine derivatives, their preparation processes and uses as chemical herbicides in agriculture.